Cite
Levine KM, Priedigkeit N, Basudan A, et al. FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype. NPJ Breast Cancer. 2019;5:19doi: 10.1038/s41523-019-0114-x.
Levine, K. M., Priedigkeit, N., Basudan, A., Tasdemir, N., Sikora, M. J., Sokol, E. S., Hartmaier, R. J., Ding, K., Ahmad, N. Z., Watters, R. J., Weiss, K. R., Blohmer, J. U., Denkert, C., Machleidt, A., Karsten, M. M., Boisen, M. M., Elishaev, E., Lucas, P. C., Lee, A. V., & Oesterreich, S. (2019). FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype. NPJ breast cancer, 519. https://doi.org/10.1038/s41523-019-0114-x
Levine, Kevin M, et al. "FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype." NPJ breast cancer vol. 5 (2019): 19. doi: https://doi.org/10.1038/s41523-019-0114-x
Levine KM, Priedigkeit N, Basudan A, Tasdemir N, Sikora MJ, Sokol ES, Hartmaier RJ, Ding K, Ahmad NZ, Watters RJ, Weiss KR, Blohmer JU, Denkert C, Machleidt A, Karsten MM, Boisen MM, Elishaev E, Lucas PC, Lee AV, Oesterreich S. FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype. NPJ Breast Cancer. 2019 Jun 27;5:19. doi: 10.1038/s41523-019-0114-x. eCollection 2019. PMID: 31263748; PMCID: PMC6597581.
Copy
Download .nbib